Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ARMPCompany Name
ARMATA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTARMATA PHARMACEUTICALS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ARMP - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -69.5M | $ -25.71M | 0% |
| 3/31/2025 | $ -53.78M | $ -426K | 0% |
| 12/31/2024 | $ -48.02M | $ -18.92M | 0% |
| 9/30/2024 | $ -50.97M | $ -41.36M | 0% |
| 6/30/2024 | $ -46.1M | $ -67.04M | 0% |
| 3/31/2024 | $ -56.51M | $ -79.58M | 0% |
| 12/31/2023 | $ -32.06M | $ -69.05M | 0% |
| 9/30/2023 | $ -12.39M | $ -59.51M | 0% |
| 6/30/2023 | $ 19.14M | $ -36.97M | -193.1% |
| 3/31/2023 | $ 22.45M | $ -42.63M | -189.93% |
Key Performance Insights, Last 5 Years
- ARMATA PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROE stands at -81.82%.
- Over the past 5 years, ARMATA PHARMACEUTICALS INC's average ROE has been -99.69%.
- The median ROE for ARMATA PHARMACEUTICALS INC during this period was -87.66%
- ARMATA PHARMACEUTICALS INC reached its highest ROE over the past 5 years at -42.95%.
- The lowest ROE recorded by ARMATA PHARMACEUTICALS INC in the same timeframe -193.1%
ARMATA PHARMACEUTICALS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ARMATA PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -20.14M ] / Equity [ $ 24.62M ]
(=) ROE [ -81.82% ] ARMP - Return on Equity, Last 5 years
-193.1%
Minimum
Jun 30, 2023
-42.95%
Maximum
Mar 31, 2022
-99.69%
Average
-87.66%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |